Announced Sat, 20 Jun · 19:07 IST
Subsidiary drug license suspended for 10 days in Pune
General View source PDF
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.8%1-day move
₹844.85
prior close
₹845.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-0.2-0.2-0.5-0.8-0.4-0.7-5.3-4.3-2.9-4.0-15.8——
Up moveDown movePending
AI summary
Medplus subsidiary Optival Health Solutions received a 10-day drug license suspension for one store at Chowk Saswad, Pune. The order, dated June 20, 2026, was issued by the Food and Drug Administration Maharashtra Pune under Rule 65 of the Drugs and Cosmetics Act, 1940. Estimated revenue impact is about Rs 2.68 lakhs.
Likely market impact
Minor impact limited to one store; revenue loss of about Rs 2.68 lakhs is immaterial to overall operations.